Chemically modified dendrimers
AssigneeGenzyme Corporation
InventorsLuis Z. Avila, Robert J. Miller, Lauren Elizabeth Young, Rajesh Vasant Kamath
Life of this patent
Estimating the term…
Abstract
Dendrimers comprising N-acyl urea terminal moieties are described herein. The dendrimers can be used, for example, in the treatment of arthritis.
Claims20
A method of treating arthritis or reducing a symptom associated with arthritis, the method comprising administering to a subject an effective amount of a dendrimer, said dendrimer comprising a plurality of branched repeating units radiating out from a central atom, multifunctional moiety, or cluster of atoms, wherein each repeating unit comprises a terminal moiety, and wherein at least about 5% of the terminal moieties include a urea of formula (I)
- wherein
- each R1 and R2 is independently C1-C6 alkyl, C1-C6 alkenyl, cyclyl, aryl, heterocyclyl, heteroaryl, cyclylalkyl, arylalkyl, or heterocyclylalkyl, heteroarylalkyl;
- any of which are optionally substituted by C1-C6 alkyl, amino, C1-C6 alkylamino, C1-C6 dialkylamino, hydroxy, C1-C6 alkoxy, and wherein either of R1 or R2 independently optionally have a net charge;
- indicates the point of attachment of the terminal moiety of formula (I) to the dendrimer;
- and
- wherein less than about 12% of the terminal moieties are covalently bound to a saccharide moiety.
Dependencies are inferred from the claim text.